The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 875-883

  Raetz, Elizabeth A ^a,c   Perkins, Sherrie L ^b   Carlson, Marlee A ^a   Schooler, Kevin P ^b   Carroll, William L ^a,b,c   Virshup, David M ^a,b,c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Division of Pediatric Hematology Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; COUMAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) B; HYBRID PROTEIN; LIGAND; MYC PROTEIN; NUCLEOPHOSMIN; PROTEIN; RNA; TYROSINE; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION 5; CONTROLLED STUDY; ENZYME ACTIVATION; LARGE CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; T CELL LYMPHOMA;

EID: 0036731862     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64248-4     Document Type: Article

References (44)

1. Non-Hodgkin's lymphoma in childhood
2. CD30(+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology
3. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Munster Group
4. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma
5. ALK+ lymphoma: Clinico-pathological findings and outcome
6. The t(2;5) in human lymphomas
7. ALK-positive lymphoma: A single-disease with a broad spectrum of morphology
8. Fusion of a kinase gene, ALK, to a nucleolar protein gene NPM, in non-Hodgkin's lymphoma
9. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
10. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
11. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
12. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity
13. Major nucleolar proteins shuttle between nucleus and cytoplasm
14. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth
15. Interaction of nucleolar phospho-protein B23 with nucleic acids
16. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
17. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1 a fibroblasts
18. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice
19. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity
20. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)
21. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
22. Switching signals on or off by receptor dimerization
23. Cell signaling by receptor tyrosine kinases
24. Receptor protein-tyrosine kinases and their signal transduction pathways
25. Coumermycin-induced dimerization of GyrB-containing fusion proteins
26. A versatile synthetic dimerizer for the regulation of protein-protein interactions
27. Controlling signal transduction with synthetic ligands
28. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization
29. Action of Myc in vivo - Proliferation and apoptosis
30. Mechanisms of apoptosis by c-Myc
31. Molecular biology of Burkitt's lymphoma
32. MYC oncogenes and human neoplastic disease
33. Expression of the c-Myc protein in childhood medullo-blastoma
34. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus
35. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques
36. Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues
37. The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry
38. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease
39. The expression of myc and ras oncogene protein in childhood lymphomas
40. Degradation of nuclear oncoproteins by the ubiquitin system in vitro
41. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
42. c-Myc target genes involved in cell growth, apoptosis, and metabolism
43. The transcriptional program of a human B cell line in response to Myc
44. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas